Neuropace Stock Forecast - Accumulation Distribution
| NPCE Stock | USD 9.00 0.19 2.07% |
Neuropace Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Neuropace stock prices and determine the direction of Neuropace's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Neuropace's historical fundamentals, such as revenue growth or operating cash flow patterns.
Neuropace |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 2256.89 | 0.0499 |
| Check Neuropace Volatility | Backtest Neuropace | Information Ratio |
Neuropace Trading Date Momentum
| On November 22 2024 Neuropace was traded for 9.00 at the closing time. The top price for the day was 9.22 and the lowest listed price was 8.76 . There was no trading activity during the period 0.0. Lack of trading volume on November 22, 2024 did not cause price change. The trading delta at closing time against the current closing price is 2.44% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Neuropace to competition |
Other Forecasting Options for Neuropace
For every potential investor in Neuropace, whether a beginner or expert, Neuropace's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neuropace Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neuropace. Basic forecasting techniques help filter out the noise by identifying Neuropace's price trends.View Neuropace Related Equities
| Risk & Return | Correlation |
Neuropace Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Neuropace's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Neuropace's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Neuropace Market Strength Events
Market strength indicators help investors to evaluate how Neuropace stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neuropace shares will generate the highest return on investment. By undertsting and applying Neuropace stock market strength indicators, traders can identify Neuropace entry and exit signals to maximize returns.
Neuropace Risk Indicators
The analysis of Neuropace's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neuropace's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neuropace stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.44 | |||
| Semi Deviation | 3.21 | |||
| Standard Deviation | 5.38 | |||
| Variance | 28.98 | |||
| Downside Variance | 12.66 | |||
| Semi Variance | 10.29 | |||
| Expected Short fall | (4.19) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Neuropace is a strong investment it is important to analyze Neuropace's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuropace's future performance. For an informed investment choice regarding Neuropace Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Neuropace to cross-verify your projections. For information on how to trade Neuropace Stock refer to our How to Trade Neuropace Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuropace. If investors know Neuropace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuropace listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.98) | Revenue Per Share 2.697 | Quarterly Revenue Growth 0.282 | Return On Assets (0.15) | Return On Equity (2.15) |
The market value of Neuropace is measured differently than its book value, which is the value of Neuropace that is recorded on the company's balance sheet. Investors also form their own opinion of Neuropace's value that differs from its market value or its book value, called intrinsic value, which is Neuropace's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuropace's market value can be influenced by many factors that don't directly affect Neuropace's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuropace's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuropace is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuropace's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.